Influenza

Study of a Pandemic Influenza Vaccine in Children

NCT00370864 | PHASE 2 | INTERVENTIONAL

The World Health Organisation has warned that an influenza pandemic is inevitable. The avian influenza strain H5N1 is one of the leading candidates to cause the next influenza pandemic. Children are likely to be a special target group for vaccination; therefore, this study will test the safety and immunogenicity of an H5N1 pandemic influenza vaccine in healthy children.

2 Sites

220 Participants

COMPLETED

6 Months to 8 Years

If interested, contact clinicaltrials@cslbehring.com or +1 610-878-4697 for more information

CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy

Find closest sites:

SUBMIT

Murdoch Childrens Research Institute

Melbourne,Victoria,Australia,3052

Princess Margaret Hospital for Children

Perth,Western Australia,Australia,3052

Study Eligibility Criteria

Inclusion Criteria

* Healthy children aged greater or equal to 6 months to less than 9 years
* Normal gestation period

Exclusion Criteria

* History of clinically significant medical conditions
* History of Guillain Barre syndrome or active neurological disease

Additional Studies

Additional studies can be found at ClinicalTrials.gov